As of August 28, 2026, Prime Medicine, Inc. (PRME) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Prime Medicine, Inc. has a market capitalization of $641.19M, 181.38M shares outstanding, 194 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise
model 55%
• Critical: only 2.8 months cash remaining
🔄 Reverse Split
model est. 15%
• Only 3 months cash — financial pressure
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$641.19M
Shares Outstanding181.38M
Float108.73M
Cash$47.45M
Debt$114.51M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 7.4% shares (2026Q1 vs prior)
194 institutional holders · 112.26M shares
#1
Alphabet Inc.
16.56M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
8.95M shares
#3
BlackRock, Inc.
8.50M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest35.00M
Days to Cover12.9
% of Float32.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2024-12-31
xbrl
XBRL CONVERTIBLE
2022-12-31
EFFECT
EFFECT
2026-03-04
4
INSIDER TRANSACTION
2026-02-27
4
INSIDER TRANSACTION
2026-02-24
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual PRME Dilution Snapshot
Prime Medicine, Inc. (PRME) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for PRME: EFFECT on 2026-03-04; 4 on 2026-02-27; 4 on 2026-02-24.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track PRME Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRME — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for PRME
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.